Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
American Journal of Human Genetics
|
September 24, 2004
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder
Colin A Hodgkinson, David Goldman, Judith Jaeger, et al.
American Journal of Medical Genetics
|
July 13, 2002
No evidence for phenotypic variation between probands in case-control versus family-based association studies of schizophrenia
Anil K Malhotra, John A Bates, Judith Jaeger, et al.
Alzheimer'S Research & Therapy
|
March 19, 2013
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
Curtis Tatsuoka, Huiyun Tseng, Judith Jaeger, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study
Pamela Ventola, Judith Jaeger, Christopher J Keary, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 28, 2013
Combining efficacy and completion rates with no data imputation: a composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials
Jonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, et al.
Chest
|
November 11, 2024
Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the Wake-Promoting Agent Solriamfetol on Cognitive Function in OSA With Excessive Daytime Sleepiness and Cognitive Impairment
Hans P A Van Dongen, Eileen B Leary, Christopher Drake, et al.
International Psychogeriatrics
|
November 22, 2018
Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria - CORRIGENDUM
Zahinoor Ismail, Jennifer Gatchel, Daniel R Bateman, et al.
Psychopharmacology
|
May 4, 2013
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Aurelija Jucaite, John Öhd, Alexandra S Potter, et al.
International Psychogeriatrics
|
September 14, 2017
Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria
Zahinoor Ismail, Jennifer Gatchel, Daniel R Bateman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 9, 2019
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
Nancy Maserejian, Shijia Bian, Wenting Wang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
American Journal of Human Genetics
|
September 24, 2004
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder
Colin A Hodgkinson, David Goldman, Judith Jaeger, et al.
American Journal of Medical Genetics
|
July 13, 2002
No evidence for phenotypic variation between probands in case-control versus family-based association studies of schizophrenia
Anil K Malhotra, John A Bates, Judith Jaeger, et al.
Alzheimer'S Research & Therapy
|
March 19, 2013
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
Curtis Tatsuoka, Huiyun Tseng, Judith Jaeger, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE study
Pamela Ventola, Judith Jaeger, Christopher J Keary, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 28, 2013
Combining efficacy and completion rates with no data imputation: a composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials
Jonathan Rabinowitz, Nomi Werbeloff, Ivo Caers, et al.
Chest
|
November 11, 2024
Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the Wake-Promoting Agent Solriamfetol on Cognitive Function in OSA With Excessive Daytime Sleepiness and Cognitive Impairment
Hans P A Van Dongen, Eileen B Leary, Christopher Drake, et al.
International Psychogeriatrics
|
November 22, 2018
Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria - CORRIGENDUM
Zahinoor Ismail, Jennifer Gatchel, Daniel R Bateman, et al.
Psychopharmacology
|
May 4, 2013
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Aurelija Jucaite, John Öhd, Alexandra S Potter, et al.
International Psychogeriatrics
|
September 14, 2017
Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria
Zahinoor Ismail, Jennifer Gatchel, Daniel R Bateman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
November 9, 2019
Practical algorithms for amyloid β probability in subjective or mild cognitive impairment
Nancy Maserejian, Shijia Bian, Wenting Wang, et al.
Page
of 7